ReviewPharmaceuticals (Basel, Switzerland)2024

Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review.

Teodor Salmen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.